Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
about
Informatics derived materials databases for multifunctional propertiesHemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunityPolyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody ResponsesSafety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticlesRespiratory nanoparticle-based vaccines and challenges associated with animal models and translationDevelopment and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen.The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.Plague Vaccines: Status and Future.Association rule mining of cellular responses induced by metal and metal oxide nanoparticles.Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles.Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis.pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses.Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.A Simple Two Dimensional Model of Methanol
P2860
Q28084818-86CD0012-6DA4-4677-A4E3-46AA6F68F5EBQ30370494-F9E51FBE-4A61-42D5-937E-EB1E4DABC95BQ33710195-CBF6F52C-8CD7-4CD4-8EDB-D88644D6B8BAQ34871862-CD2D4D81-4879-45C9-8303-900DF85095D1Q35887551-F8382947-55FB-490A-ADBA-E9CB96B76E22Q36582010-A1E11631-9C23-4995-B776-C0E4579107AFQ36598433-A635A0E2-E259-498A-81D1-7FFE3C2AB1D2Q36642860-2EA58AA8-BA63-49D7-92F6-AA5F13D74E10Q36957938-C7B1363B-22BE-4B4B-8A00-C81F2C9928D2Q38131659-E8389B90-D9E6-4723-966B-804D18002D81Q38693411-DD849CCA-D615-4002-BBFF-22F9C4CD0F4CQ38722460-AD9508FD-4661-471D-9621-CF39883A430FQ38757220-C802D428-4A46-45AA-9FA8-1E0EB9786DC8Q38813137-FEBA9756-6284-477C-BF73-401D1302EF7CQ39059539-AAA19BEA-1F7A-4C7D-922F-21C6E85C5AF5Q41382022-30551E3F-1F6D-44B6-934D-DDBD353F9014Q41389065-7A27484C-84C2-44C5-B806-E79383D70C73Q41879397-5D29C726-57D9-47AE-86AD-C9DD82AFFA1BQ42114702-3710B8F7-952D-4F8B-9B72-02DFF354FD15Q42926219-3761D7A5-6BC7-4529-B15A-22113836FE83Q46571918-AD3E0337-4DBC-491E-B5DA-481A999168B1Q46989472-01B5F71E-DD9F-4965-B5AD-FBFB006B75CFQ47165034-82FF319D-490E-419C-ADB4-037F359C7D45Q50005095-3724F114-1B81-48ED-87AF-4E9ABAEC5857Q50317606-6697B4CF-BC01-4BFC-AA18-CCB1FE6C6147Q50928936-644E396B-CD81-47C8-9F80-21E05214E3EFQ51732398-E4D4760C-96E9-4285-B45C-CB22997992FBQ58568281-07E65CED-A77E-4938-A06B-A294EE0617D3
P2860
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
@ast
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
@en
type
label
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
@ast
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
@en
prefLabel
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
@ast
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.
@en
P2093
P2860
P356
P1433
P1476
Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants
@en
P2093
Balaji Narasimhan
Brenda Carrillo-Conde
Bret D Ulery
Bryan H Bellaire
Chang Sun Kong
Devender Kumar
Krishna Rajan
Latrisha K Petersen
Michael J Wannemuehler
Scott R Broderick
P2860
P2888
P356
10.1038/SREP00198
P407
P577
2011-12-16T00:00:00Z